Prevalence of Leptospirosis Titers in Dogs Affected with Acute and Chronic Seizures
World Small Animal Veterinary Association World Congress Proceedings, 2005
S. P. Bernardo, MVZ, Residente Hospital Veterinario UNAM; S. M. Carlos Eduardo, MVZ, Esp. Ms. C. Académico ortopedia-Neurología Hospital Veterinario UNAM; G. S. Gustavo Adolfo, MVZ, Esp. Ms C. Ph D., Dipl. Académico oftalmología Hospital veterinario UNAM
Veterinary medical teacher hospital of the college of veterinary medicine at the University of Mexico, Ciudad Universitaria, circuito exterior s/n Coyoacan C.P 04510. Facultad de medicina veterinaria y zootecnia. Hospital veterinario.

Leptospirosis is an infectious disease frequently observed in dogs. Some dogs with positive titters to leptospirosis have a clinical history of neurological disease. The relationship between the presence of acute or chronic seizure and the incidence of leptospirosis has not been evaluated.

Patients presented to the veterinary medical teacher hospital at the University of Mexico, during the period January 2004-November 2004, with clinical history of acute o chronic seizure, were randomly evaluated for the presence of distemper and leptospirosis serum titters and dark shield.

A total number of 44 dogs with clinical history of seizure that were not vaccinated before, were evaluated. Twenty nine were randomly evaluated for leptospirosis, and thirty six were randomly evaluated for distemper.

Eight dogs (27.5%) had positive titters and dark shield for leptospirosis and 16 patients (44.4%) showed titters positive to distemper. From the others 25 patients, 13 were negatives to both test, and 7 were negative to the single test that was selected.

Our results demonstrated a lower incidence of leptospirosis when compared with distemper titters. Even the incidence of leptospirosis between the neurological patients is low; our results demonstrated that leptospirosis may be considered as a related etiological agent when considering differential diagnosis for seizures in dogs. Given the little information that exists on the leptospirosis like etiologic agent in neurological transtorns in veterinary medicine, it suggests that this subdiagnosing leptospirosis associated a neurologic transtorns.

References

1.  Panicker J. N., Mammachan R, et al. Primary neuroleptospirosis. Department of Medicine, Medical College, Thiruvananthapuram, Kerala, India. Postgrad Med J 2001;77:589-590 (September).

2.  Abraham M. The central nervous system in leptospirosis. Kerala Medical Journal 1998;38:21-22.

3.  The clinico-morphological characteristics of the nervous system lesions in icterohemorrhagic leptospirosis. Matiash VI, Anisimova IuN.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

S. P. Bernardo, MVZ
Residente Hospital Veterinario UNAM


MAIN : Abstracts, Poster : Leptospirosis Titers: Seizures
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27